- FOUNDED 2007
Overview
The Cancer Genetics Group provides a national forum for discussion and interaction among clinical, research and support service personnel engaged in cancer genetics research, treatment and management.
Originally established as the Familial Cancer Group within COSA, the Group merged with the Human Genetics Society of Australasia (HGSA) Cancer Genetics Special Interest Group in 2020.
The Group is represented by an Executive Committee with interest in the germline and somatic aspects of cancer genetics.
Membership includes a broad range of professionals, including: Clinical Geneticists, Genetic Counsellors, Oncologists, Scientists, Researchers and others who have an interest in cancer genetics across Australasia.
Some of the issues in which the Group has interest include:
- supporting continuing education of cancer health care professionals on relevant cancer genetics topics
- facilitating networks within familial and/or somatic cancer genetics communities in Australia to accelerate the translation of genetic discoveries into meaningful improvements in care pathways and outcomes for patients
- development of consistent clinical protocols across Australia
- advocacy on issues related to cancer genetics
The Group holds professional development days and webinars, and contributes to various scientific meetings.
Group information
COSA and HGSA Cancer Genetics Group Terms of Reference – Council approved 16 October 2020
What’s the latest
Group Chair
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow

COSAoncology 2 days ago
In partnership with @VCCCAlliance a genomics workshop to unite leaders in cancer care, research, policy and consumer advocacy to review progress, align initiatives, strengthen patient pathways, and build workforce capability. Register today!
Read More >
COSAoncology 8 days ago
Our Cancer Pharmacists Group Clinical Development Workshop is back! This 3-hour educational afternoon will take place on Tuesday 11 November at the Adelaide Convention Centre. COSA CPG members and other interested pharmacists are encouraged to attend.
Read More >
COSAoncology 9 days ago
Save the date for the PGX Debate! COSA, @CAPhO_ACPhO @ISOPPorg and @BOPACommittee leaders will face off in a lively 3-minute-thesis-style debate - Is pharmacogenomics over-rated? - Evidence, energy and humour guaranteed! Tuesday 28 October 8:00PM AEDT
Read More >
COSAoncology 16 days ago
It is just six weeks till the multidisciplinary cancer care community meets in Adelaide for #COSAIPOS2025 to share insights, highlight innovation and influence best practice. View the packed program
Read More >
COSAoncology 23 days ago
Catch the Highlights of ISOPP CAPhO Symposium 2025 in a live webinar Saturday 27 September 7:30am AEST. Speakers include @DrKEWatson, Melanie Danilak & Prof Lita Chew. The webinar is free for members of @COSAoncology @ISOPPorg @CAPhO_ACPhO @BOPACommittee.
Read More >
COSAoncology 23 days ago
Our September member newsletter is out now. Check your inbox for COSA news – opportunities, group and affiliate updates, webinars, journal articles and more. Or log in and read it online anytime at
Read More >
COSAoncology 25 days ago
Check your inbox for the September Nutrition Group eNews for journal articles, PD, resources and more. If you're not subscribed, login to your COSA member account
Read More >
COSAoncology one month ago
@COSAoncology @ASCO @EuropeanCancer are using their collective voices to raise awareness of challenges impacting the wellbeing of health professionals and to define principles for creating healthy workplace cultures in health systems. See Lancet Oncology
Read More >
COSAoncology one month ago
Exercise & Cancer / Global Oncology Group Fellowship opportunities! COSA is offering two Fellowships to early-mid career researchers to coordinate and lead a study to develop a model of care for exercise oncology for a lower-middle-income country setting.
Read More >
COSAoncology one month ago
The latest Survivorship eNews is out now! With working group updates, new COSA-endorsed resources, journal articles, COSA-IPOS 2025 key survivorship sessions & more. Check your inbox, visit
Read More >